NBP24518701
Testosterone Antibody (4E1G2), Novus Biologicals™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | NBP24518701-Each-of-1 | In Stock | ₹ 44,833.44 |
NBP24518701 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 44,833.44
GST (18%): ₹ 8,070.019
Total Price: ₹ 52,903.459
Antigen
Testosterone
Classification
Monoclonal
Concentration
0.2 mg/mL
Dilution
Immunohistochemistry-Paraffin 1:10-1:500, Radioimmunoassay, SDS-Page
Host Species
Mouse
Purification Method
Protein A or G purified
Regulatory Status
RUO
Test Specificity
This MAb is highly specific to testosterone. Its affinity constant for testosterone is ∼1010M-1. In competitive binding immunoassay, it reacts with testosterone 100%, 11-beta-hydroxy testosterone 3.3%, 17-alpha-methyl testosterone
Content And Storage
Store at 4C.
Isotype
IgG1 κ
Applications
Immunohistochemistry (Paraffin), Radioimmune Assays (RIA), SDS-Page
Clone
4E1G2
Conjugate
Unconjugated
Formulation
10mM PBS and 0.05% BSA with 0.05% Sodium Azide
Immunogen
Testosterone 3 CMO conjugated to BSA
Quantity
0.1 mg
Primary or Secondary
Primary
Target Species
Human, All species
Form
Purified
Related Products
Description
- Ensure accurate, reproducible results in ELISA, Radioimmunoassay Testosterone Monoclonal specifically detects Testosterone in Non-species specific samples
- It is validated for ELISA, Immunohistochemistry, Immunohistochemistry-Paraffin, Radioimmunoassay.
Compare Similar Items
Show Difference
Antigen: Testosterone
Classification: Monoclonal
Concentration: 0.2 mg/mL
Dilution: Immunohistochemistry-Paraffin 1:10-1:500, Radioimmunoassay, SDS-Page
Host Species: Mouse
Purification Method: Protein A or G purified
Regulatory Status: RUO
Test Specificity: This MAb is highly specific to testosterone. Its affinity constant for testosterone is ∼1010M-1. In competitive binding immunoassay, it reacts with testosterone 100%, 11-beta-hydroxy testosterone 3.3%, 17-alpha-methyl testosterone
Content And Storage: Store at 4C.
Isotype: IgG1 κ
Applications: Immunohistochemistry (Paraffin), Radioimmune Assays (RIA), SDS-Page
Clone: 4E1G2
Conjugate: Unconjugated
Formulation: 10mM PBS and 0.05% BSA with 0.05% Sodium Azide
Immunogen: Testosterone 3 CMO conjugated to BSA
Quantity: 0.1 mg
Primary or Secondary: Primary
Target Species: Human, All species
Form: Purified
Antigen:
Testosterone
Classification:
Monoclonal
Concentration:
0.2 mg/mL
Dilution:
Immunohistochemistry-Paraffin 1:10-1:500, Radioimmunoassay, SDS-Page
Host Species:
Mouse
Purification Method:
Protein A or G purified
Regulatory Status:
RUO
Test Specificity:
This MAb is highly specific to testosterone. Its affinity constant for testosterone is ∼1010M-1. In competitive binding immunoassay, it reacts with testosterone 100%, 11-beta-hydroxy testosterone 3.3%, 17-alpha-methyl testosterone
Content And Storage:
Store at 4C.
Isotype:
IgG1 κ
Applications:
Immunohistochemistry (Paraffin), Radioimmune Assays (RIA), SDS-Page
Clone:
4E1G2
Conjugate:
Unconjugated
Formulation:
10mM PBS and 0.05% BSA with 0.05% Sodium Azide
Immunogen:
Testosterone 3 CMO conjugated to BSA
Quantity:
0.1 mg
Primary or Secondary:
Primary
Target Species:
Human, All species
Form:
Purified
Antigen: Testosterone
Classification: Monoclonal
Concentration: 0.2 mg/mL
Dilution: Immunohistochemistry-Paraffin 1:10-1:500, Radioimmunoassay, SDS-Page
Host Species: Mouse
Purification Method: Protein A or G purified
Regulatory Status: RUO
Test Specificity: This MAb is highly specific to testosterone. Its affinity constant for testosterone is ∼1010M-1. In competitive binding immunoassay, it reacts with testosterone 100%, 11-beta-hydroxy testosterone 3.3%, 17-alpha-methyl testosterone
Content And Storage: Store at 4C.
Isotype: IgG1 κ
Applications: Immunohistochemistry (Paraffin), Radioimmune Assays (RIA), SDS-Page
Clone: 4E1G2
Conjugate: Unconjugated
Formulation: 10mM PBS and 0.05% BSA with 0.05% Sodium Azide
Immunogen: Testosterone 3 CMO conjugated to BSA
Quantity: 0.2 mg
Primary or Secondary: Primary
Target Species: Human, All species
Form: Purified
Antigen:
Testosterone
Classification:
Monoclonal
Concentration:
0.2 mg/mL
Dilution:
Immunohistochemistry-Paraffin 1:10-1:500, Radioimmunoassay, SDS-Page
Host Species:
Mouse
Purification Method:
Protein A or G purified
Regulatory Status:
RUO
Test Specificity:
This MAb is highly specific to testosterone. Its affinity constant for testosterone is ∼1010M-1. In competitive binding immunoassay, it reacts with testosterone 100%, 11-beta-hydroxy testosterone 3.3%, 17-alpha-methyl testosterone
Content And Storage:
Store at 4C.
Isotype:
IgG1 κ
Applications:
Immunohistochemistry (Paraffin), Radioimmune Assays (RIA), SDS-Page
Clone:
4E1G2
Conjugate:
Unconjugated
Formulation:
10mM PBS and 0.05% BSA with 0.05% Sodium Azide
Immunogen:
Testosterone 3 CMO conjugated to BSA
Quantity:
0.2 mg
Primary or Secondary:
Primary
Target Species:
Human, All species
Form:
Purified
Antigen: CA19-9/Sialyl Lewisa
Classification: Monoclonal
Concentration: 0.2mg/mL
Dilution: Flow Cytometry 0.5 - 1ug/million cells, Immunohistochemistry-Paraffin 1:50-1:100, Immunofluorescence 1:25 - 1:50
Host Species: Mouse
Purification Method: Protein A or G purified
Regulatory Status: RUO
Test Specificity: CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed, paraffin-embedded tissues.
Content And Storage: Store at 4C.
Isotype: IgM κ
Applications: Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence
Clone: 121SLE
Conjugate: Unconjugated
Formulation: 10mM PBS and 0.05% BSA with 0.05% Sodium Azide
Immunogen: Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
Quantity: 0.02 mg
Primary or Secondary: Primary
Target Species: Human
Form: Purified
Antigen:
CA19-9/Sialyl Lewisa
Classification:
Monoclonal
Concentration:
0.2mg/mL
Dilution:
Flow Cytometry 0.5 - 1ug/million cells, Immunohistochemistry-Paraffin 1:50-1:100, Immunofluorescence 1:25 - 1:50
Host Species:
Mouse
Purification Method:
Protein A or G purified
Regulatory Status:
RUO
Test Specificity:
CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed, paraffin-embedded tissues.
Content And Storage:
Store at 4C.
Isotype:
IgM κ
Applications:
Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence
Clone:
121SLE
Conjugate:
Unconjugated
Formulation:
10mM PBS and 0.05% BSA with 0.05% Sodium Azide
Immunogen:
Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
Quantity:
0.02 mg
Primary or Secondary:
Primary
Target Species:
Human
Form:
Purified
Antigen: CA19-9/Sialyl Lewisa
Classification: Monoclonal
Concentration: 0.2mg/mL
Dilution: Flow Cytometry 0.5 - 1ug/million cells, Immunohistochemistry-Paraffin 1:50-1:100, Immunofluorescence 1:25 - 1:50
Host Species: Mouse
Purification Method: Protein A or G purified
Regulatory Status: RUO
Test Specificity: CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed, paraffin-embedded tissues.
Content And Storage: Store at 4C.
Isotype: IgM κ
Applications: Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence
Clone: 121SLE
Conjugate: Unconjugated
Formulation: 10mM PBS and 0.05% BSA with 0.05% Sodium Azide
Immunogen: Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
Quantity: 0.1 mg
Primary or Secondary: Primary
Target Species: Human
Form: Purified
Antigen:
CA19-9/Sialyl Lewisa
Classification:
Monoclonal
Concentration:
0.2mg/mL
Dilution:
Flow Cytometry 0.5 - 1ug/million cells, Immunohistochemistry-Paraffin 1:50-1:100, Immunofluorescence 1:25 - 1:50
Host Species:
Mouse
Purification Method:
Protein A or G purified
Regulatory Status:
RUO
Test Specificity:
CA19-9, a carbohydrate epitope expressed on a high MW (>400kDa) mucin glycoprotein, is a sialyl Lewisa structure which is synthesized from type 1 blood group precursor chains and is present in individuals expressing the Lewisa and/or Lewisb blood group antigens. In normal tissues, sialyl Lewisa antigen is present in ductal epithelium of the breast, kidney, salivary gland, and sweat glands. Its expression is greatly enhanced in serum as well as in the majority of tumor cells in gastrointestinal (GI) carcinomas, including adenocarcinomas of the stomach, intestine, and pancreas. Preoperative elevated CA19-9 levels in patients with stage I pancreatic carcinoma decrease to normal values following surgery. When used serially, CA19-9 can predict recurrence of disease prior to radiographic or clinical findings. This MAb is excellent for staining of formalin-fixed, paraffin-embedded tissues.
Content And Storage:
Store at 4C.
Isotype:
IgM κ
Applications:
Flow Cytometry, Immunohistochemistry (Paraffin), Immunofluorescence
Clone:
121SLE
Conjugate:
Unconjugated
Formulation:
10mM PBS and 0.05% BSA with 0.05% Sodium Azide
Immunogen:
Precipitin lines obtained after immuno-diffusion using MAb 116-NS-19-9 and mucins isolated from an ovarian cyst of a Lewis A+B- patient (0Le).
Quantity:
0.1 mg
Primary or Secondary:
Primary
Target Species:
Human
Form:
Purified